Innerspace and PDA announced a long-term strategic partnership to develop PDA training course.
Innsbruck, Austria June 2023 – The Parenteral Drug Association (PDA) and Innerspace share the same mission of delivering high-quality and impactful education to the industry. In line with this goal, our Innerspace Virtual Reality Simulator and its built-in Frame-by-Frame Risk Profiling capabilities will become part of PDA training courses for professionals in the pharmaceutical and biopharmaceutical industries.
The Parenteral Drug Association (PDA) and Innerspace have announced a long-term strategic partnership to develop PDA training courses that incorporate the use of VR Simulators designed with frame-by-frame risk profiling capabilities. This partnership aims to create a series of hybrid lecture/VR data-driven, immersive, and effective training courses for professionals in the pharmaceutical and biopharmaceutical industries.
The first new PDA/Innerspace training course is called Fundamentals of Aseptic Processing, which will be held in Carlsbad, California, in July.
Key Benefits of the VR Training Simulator
“We are thrilled to partner with Innerspace to provide our members and the industry with innovative and effective training solutions that brings the VR cleanroom into any location,” said PDA President and CEO Glenn Wright. “I really like the built in frame-by-frame risk profiling capabilities that can provide trainees with immediate feedback on errors made. When combined with PDA course content, it allows us to offer a new way to reach the industry. We believe this partnership will greatly benefit our industry and our shared goal of delivering world class trainings in locations where a traditional cleanroom environment is not available.”
All PDA training courses are designed to meet the pharmaceutical industry’s specific training needs and the health authorities’ expectations.
“We plan to gradually connect PDA training material with information from Innerspace’s frame-by-frame risk profiling, which is a new technology used to create extensive data libraries about risks related to specific processes.” Innerspace’s Managing Director and Chief Methodologist Sebastian Scheler said. “This approach will help us offer participants a deeper understanding of the risks involved in aseptic processing and help them apply this knowledge to their manufacturing facilities as needed.”
“Through the integration of expert insights, regulatory requirements, VR technology and risk profiling data into our course content, we aim to establish a data-driven approach to training by leveraging these resources,” said PDA VP of Education David Talmage. “We are excited to initiate this partnership with Innerspace to deliver cutting-edge training courses for the pharmaceutical industry.”
